ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.36%
US Dollar vs MXN
17.6601
-0.88%
Brent Oil
77.685
0.75%
Bitcoin
70,881.61
0.36%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bionano Genomics Inc (BNGO)

  7. Bionano Genomics Inc (BNGO) Noticias

BNGO Bionano Genomics Inc

0.904
0.00 (0.00%)
Pre Mercado
Última actualización: 06:02:12
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bionano Genomics Inc BNGO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.904 06:02:12
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.904
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/5/202407:00GLOBEBionano Announces Robust Presence at Upcoming Cytogenetics..
28/5/202407:15EDGAR2Form 8-K - Current report
28/5/202407:00GLOBEBionano Announces Private Placement of Senior Secured Notes..
21/5/202407:00GLOBEBionano Announces Three Publications Demonstrating OGM’s..
09/5/202407:00GLOBEBionano Announces Series of Major Advancements to its Suite..
08/5/202416:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/5/202415:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:02EDGAR2Form 8-K - Current report
08/5/202415:01GLOBEBionano Reports First Quarter 2024 Results and Highlights..
01/5/202407:00GLOBEBionano to Report First Quarter 2024 Financial Results and..
30/4/202415:05GLOBEBionano to Present at the RBC Capital Markets 2024 Global..
24/4/202407:00GLOBEBionano Announces Publication Showing OGM’s High Resolution..
17/4/202407:00GLOBEBionano and Diagens Sign Partnership to Commercialize the..
11/4/202407:00GLOBEBionano Announces Publication Showing that OGM Detects Over..
04/4/202412:44GLOBEBionano Announces $10 Million Registered Direct Offering..
03/4/202407:00GLOBEBionano Announces Publication Showing that OGM Identifies..
02/4/202407:00GLOBEBionano Announces 9 Poster Presentations and Introduces New..
19/3/202407:00GLOBEBionano Announces Publication of a Breast Cancer Study..
07/3/202407:00GLOBEBionano Announces Extensive Lineup of Content at American..
05/3/202416:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202415:23EDGAR2Form 8-K - Current report
05/3/202415:01GLOBEBionano Reports Fourth Quarter and Full-Year 2023 Results..
29/2/202407:00GLOBEBionano to Present at TD Cowen’s 44th Annual Health Care..
28/2/202407:16EDGAR2Form 8-K - Current report
28/2/202407:01GLOBEBionano to Report Fourth Quarter and Year End 2023 Financial..
28/2/202407:00GLOBEBionano Announces Amendment to Debt Financing Arrangement to..
22/2/202407:00GLOBEAmerican College of Medical Genetics and Genomics Includes..
31/1/202407:00GLOBEBionano to Participate in the BTIG Snowbird MedTech, Digital..
30/1/202407:00GLOBEBionano’s Symposium 2024 Featured Presentations from its..
24/1/202407:00GLOBEBionano Announces Publication of Interim Readout from Second..
23/1/202407:00GLOBEBionano Announces Full Commercial Release of the Stratys™..
19/1/202407:00GLOBEBionano Announces the Final Speaker Lineup for 2024..
11/1/202415:01GLOBEBionano Announces Peer-Reviewed Publication from its..
10/1/202407:00GLOBEBionano Announces 2024 Symposium: Four Consecutive Days of..
08/1/202407:10EDGAR2Form 8-K - Current report
08/1/202407:00GLOBEBionano Reports Preliminary Fourth Quarter and Full-Year..
28/12/202307:00GLOBEBionano Announces Significant Upgrades to its Bionano Solve..
26/12/202307:00GLOBEBionano Announces Publication of Largest Prospective..
14/12/202307:00GLOBECancers Journal Publishes Special Issue Dedicated to OGM’s..
12/12/202307:00GLOBEBionano Laboratories Announces Publication of the Analytical..
06/12/202307:00GLOBEBionano Announces Presentations Featuring OGM Utility Across..
30/11/202307:00GLOBEStudy Shows that OGM Plays an Important Role in Efficient..
29/11/202309:04GLOBEBionano Announces Publication Demonstrating Utility of OGM..
24/11/202312:05EDGAR2Form 8-K - Current report
14/11/202323:07GLOBELeddarTech Appoints Chris Stewart as Chief Financial Officer
14/11/202307:00GLOBEBionano Announces Presentation of OGM Utility Across Key..

Su Consulta Reciente

NASDAQ
BNGO
Bionano Genomics
COIN
NESTETH
NEST
BOV
PDTC3R
Padtec ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados